Druggability modification strategies of the diarylpyrimidine‐type non‐nucleoside reverse transcriptase inhibitors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Druggability modification strategies of the diarylpyrimidine‐type non‐nucleoside reverse transcriptase inhibitors
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-01-27
DOI
10.1002/med.21760
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel
- (2020) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic channel and tolerant regions of NNIBP
- (2020) Dongwei Kang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?
- (2020) Pierre Frange et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
- (2020) Xin Li et al. Journal of Hematology & Oncology
- Metabolic and Pharmaceutical Aspects of Fluorinated Compounds
- (2020) Benjamin M. Johnson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties
- (2020) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Scaffold Hopping in Discovery of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: From CH(CN)-DABOs to CH(CN)-DAPYs
- (2020) Ting-Ting Li et al. MOLECULES
- Privileged scaffold inspired design of novel oxime-biphenyl-DAPYs in treatment of HIV-1
- (2020) Yang Yang et al. BIOORGANIC CHEMISTRY
- hERG toxicity assessment: Useful guidelines for drug design
- (2020) Amanda Garrido et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- New Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors Show Low Nanomolar Inhibition of Single and Double HIV-1 Mutant Strains
- (2020) Marianna Nalli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Introduction: Drug Metabolism and Toxicology Special Issue
- (2020) F. Peter Guengerich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure–Activity Relationship Exploration of NNIBP Tolerant Region I Leads to Potent HIV-1 NNRTIs
- (2020) Dongwei Kang et al. ACS Infectious Diseases
- Bioisosterism-based design and enantiomeric profiling of chiral hydroxyl-substituted biphenyl-diarylpyrimidine nonnucleoside HIV-1 reverse transcriptase inhibitors
- (2020) Xiaomei Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Applications of deuterium in medicinal chemistry
- (2019) Tracey Pirali et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Dihydrofuro[3,4-d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties
- (2019) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Resurrecting the Condemned: Identification of N-Benzoxaborole Benzofuran GSK8175 as a Clinical Candidate with Reduced Metabolic Liability
- (2019) Peng Zhan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles
- (2019) Boshi Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Adverse effects of chronic treatment with the Main subclasses of highly active antiretroviral therapy: a systematic review
- (2019) BF Silva et al. HIV MEDICINE
- Molecular design opportunities presented by solvent‐exposed regions of target proteins
- (2019) Xiangyi Jiang et al. MEDICINAL RESEARCH REVIEWS
- ECG interpretation
- (2019) Rebecca R Chamley et al. EUROPEAN HEART JOURNAL
- Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment
- (2019) Yali Wang et al. Expert Opinion on Drug Metabolism & Toxicology
- Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs
- (2019) Dongwei Kang et al. Acta Pharmaceutica Sinica B
- Fragment-based discovery of sulfur-containing diarylbenzopyrimidines as novel nonnucleoside reverse transcriptase inhibitors
- (2019) Sheng Han et al. CHINESE CHEMICAL LETTERS
- Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activities
- (2019) Ting Xiao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Arvinas’s PROTACs pass first safety and PK analysis
- (2019) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic Profiles
- (2019) Sheng Han et al. ACS Infectious Diseases
- Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
- (2019) Kaijun Jin et al. Acta Pharmaceutica Sinica B
- Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): Our past twenty years
- (2019) Chunlin Zhuang et al. Acta Pharmaceutica Sinica B
- Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles
- (2019) Yali Sang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anthropometric measures of central adiposity are highly concordant with predictors of cardiovascular disease risk in HIV patients
- (2018) Rebeca A Beraldo et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- The discovery of novel diarylpyri(mi)dine derivatives with high level activity against a wide variety of HIV-1 strains as well as against HIV-2
- (2018) Xueyi Lu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain
- (2018) Boshi Huang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1
- (2018) KaiJun Jin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
- (2018) Nicholas A. Meanwell JOURNAL OF MEDICINAL CHEMISTRY
- Structure-based methods to predict mutational resistance to diarylpyrimidine non-nucleoside reverse transcriptase inhibitors
- (2018) Syeda Maryam Azeem et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored “hydrophobic channel”
- (2018) Zhongxia Zhou et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery
- (2018) Dongwei Kang et al. ACS Medicinal Chemistry Letters
- Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors
- (2018) Shuang-Xi Gu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- HUMAN CYP2A6, CYP2B6 AND CYP2E1 ATROPSELECTIVELY METABOLIZE POLYCHLORINATED BIPHENYLS TO HYDROXYLATED METABOLITES
- (2018) Eric Uwimana et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- Effect of α-Methoxy Substitution on the Anti-HIV Activity of Dihydropyrimidin-4(3H)-ones
- (2018) Maxim B. Nawrozkij et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic
- (2018) Vigneshwaran Namasivayam et al. JOURNAL OF MEDICINAL CHEMISTRY
- Challenges and approaches in the discovery of human immunodeficiency virus type-1 non-nucleoside reverse transcriptase inhibitors
- (2018) Leandro Battini et al. MEDICINAL RESEARCH REVIEWS
- Novel fused pyrimidine and isoquinoline derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2016105532A1, WO2016105534A1 and WO2016105564A1
- (2017) Dongwei Kang et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents
- (2017) Valeria Famiglini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants
- (2017) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of Safe Drugs: The hERG Challenge
- (2017) Subha Kalyaanamoorthy et al. MEDICINAL RESEARCH REVIEWS
- In vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common Antiretrovirals
- (2017) Vincent T. Ciavatta et al. NEUROCHEMICAL RESEARCH
- Discovery of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the Tolerant Region I of NNIBP
- (2017) Dongwei Kang et al. ACS Medicinal Chemistry Letters
- Current assessment of heart rate variability and QTc interval length in HIV/AIDS
- (2017) Roger C. McIntosh et al. Current Opinion in HIV and AIDS
- Novel biphenyl ester derivatives as tyrosinase inhibitors: Synthesis, crystallographic, spectral analysis and molecular docking studies
- (2017) Huey Chong Kwong et al. PLoS One
- Small-Molecule PROTACS: New Approaches to Protein Degradation
- (2016) Momar Toure et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket
- (2016) Qing Meng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry
- (2016) Mônica M. Bastos et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structural optimization of pyridine-type DAPY derivatives to exploit the tolerant regions of the NNRTI binding pocket
- (2016) Wenmin Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles
- (2016) Dongwei Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- 2,6-Di(arylamino)-3-fluoropyridine Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors
- (2016) Sergey Sergeyev et al. JOURNAL OF MEDICINAL CHEMISTRY
- Stacking with No Planarity?
- (2016) Hakan Gunaydin et al. ACS Medicinal Chemistry Letters
- A novel family of diarylpyrimidines (DAPYs) featuring a diatomic linker: Design, synthesis and anti-HIV activities
- (2015) Shuang-Xi Gu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Hybrid chemistry. Part 4: Discovery of etravirine–VRX-480773 hybrids as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
- (2015) Zheng-Yong Wan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Anti-HIV diarylpyrimidine–quinolone hybrids and their mode of action
- (2015) Tian-Qi Mao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches
- (2015) Boshi Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: Design, synthesis and biological evaluation of novel imidazo[1,2-a]pyrazines
- (2015) Boshi Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of piperidin-4-yl-aminopyrimidine derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors
- (2015) Zheng-Yong Wan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pyrimidine sulfonylacetanilides with improved potency against key mutant viruses of HIV-1 by specific targeting of a highly conserved residue
- (2015) Zheng-Yong Wan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Efavirenz and the CNS: what we already know and questions that need to be answered
- (2015) Nadezda Apostolova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Applications of Fluorine in Medicinal Chemistry
- (2015) Eric P. Gillis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology
- (2014) Charlotte I.S. Barker et al. ADVANCED DRUG DELIVERY REVIEWS
- Structural modifications of CH(OH)-DAPYs as new HIV-1 non-nucleoside reverse transcriptase inhibitors
- (2014) Zi-Hong Yan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: Design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives
- (2014) Ye Tian et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors
- (2014) Zi-Hong Yan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: Discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach
- (2014) Liu Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization
- (2014) Zhaoqiang Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors
- (2014) Ge Meng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approach
- (2014) Xiao Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
- (2013) Xuwang Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Recent Advances in DAPYs and Related Analogues as HIV-1 NNRTIs
- (2012) Xuwang Chen et al. CURRENT MEDICINAL CHEMISTRY
- Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitors
- (2012) Shuang-Xi Gu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 2-(Alkyl/Aryl)Amino-6-Benzylpyrimidin-4(3H)-ones as Inhibitors of Wild-Type and Mutant HIV-1: Enantioselectivity Studies
- (2012) Dante Rotili et al. JOURNAL OF MEDICINAL CHEMISTRY
- Strategies for the Design of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Lessons from the Development of Seven Representative Paradigms
- (2012) Dongyue Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drug Salt Formation via Mechanochemistry: The Case Study of Vincamine
- (2012) Dritan Hasa et al. MOLECULAR PHARMACEUTICS
- A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study)
- (2011) Alain Nguyen et al. AIDS
- Design, synthesis and biological evaluation of cycloalkyl arylpyrimidines (CAPYs) as HIV-1 NNRTIs
- (2011) Shuang-Xi Gu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and structure–activity relationship of novel diarylpyrimidines with hydromethyl linker (CH(OH)-DAPYs) as HIV-1 NNRTIs
- (2011) Shuang-Xi Gu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and Anti-HIV Activity of Aryl-2-[(4-cyanophenyl)amino]-4-pyrimidinone hydrazones as Potent Non-nucleoside Reverse Transcriptase Inhibitors
- (2011) Xiao-Dong Ma et al. ChemMedChem
- HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design
- (2011) Peng Zhan et al. MEDICINAL RESEARCH REVIEWS
- Hybrid diarylbenzopyrimidine non-nucleoside reverse transcriptase inhibitors as promising new leads for improved anti-HIV-1 chemotherapy
- (2010) Zhao-Sen Zeng et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and anti-HIV activity of 2-naphthyl substituted DAPY analogues as non-nucleoside reverse transcriptase inhibitors
- (2010) Yong-Hong Liang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of 4-(hydroxyimino)arylmethyl diarylpyrimidine analogues as potential non-nucleoside reverse transcriptase inhibitors against HIV
- (2010) Xiao-Qing Feng et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Lead Optimization of Diarylpyrimidines as Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase
- (2010) Zhao-Sen Zeng et al. ChemMedChem
- Diarylaniline Derivatives as a Distinct Class of HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors
- (2010) Bingjie Qin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Evaluation of Diarylpyridines and Diarylanilines as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors
- (2010) Xingtao Tian et al. JOURNAL OF MEDICINAL CHEMISTRY
- Etravirine, a Next‐Generation Nonnucleoside Reverse‐Transcriptase Inhbitor
- (2009) Leonard B. Johnson et al. CLINICAL INFECTIOUS DISEASES
- Rilpivirine: a novel non-nucleoside reverse transcriptase inhibitor
- (2009) Lucy Garvey et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Structural Modifications of DAPY Analogues with Potent Anti-HIV-1 Activity
- (2008) Xiao-Qing Feng et al. ChemMedChem
- The Current Status of the NNRTI Family of Antiretrovirals Used Against HIV Infection
- (2008) Silvia Martins et al. CURRENT MEDICINAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started